Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase Inhibitor
Clinical trial NCT01610284 · COMPLETED
Trial details
- NCT number
- NCT01610284
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-07
- Primary completion
- 2015-04-29
- Enrollment
- 1147
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.